Results 11 to 20 of about 283,997 (324)

Individualization of antiretroviral therapy

open access: yesPharmacogenomics and Personalized Medicine, 2011
Rebecca Pavlos, Elizabeth J PhillipsInstitute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, AustraliaAbstract: Antiretroviral therapy (ART) has evolved considerably over the last three decades.
Pavlos R, Phillips EJ
doaj   +4 more sources

Antiretroviral Therapy in the Clinic [PDF]

open access: yesJournal of Virology, 2010
ABSTRACT Antiretroviral therapy in the developed world has resulted in substantial reductions in HIV-associated morbidity and mortality, changing an HIV diagnosis from a likely death sentence into a manageable chronic infection (F. J. Palella, Jr., K. M. Delaney, A. C. Moorman, M. O. Loveless, J. Fuhrer, G. A. Satten, D.
Athe M N, Tsibris, Martin S, Hirsch
openaire   +2 more sources

Hypertriglyceridemia in Antiretroviral Therapy [PDF]

open access: yesJournal of the International AIDS Society, 2005
Elevated serum triglycerides, total cholesterol, very low-density lipoprotein (VLDL) cholesterol, and low-density lipoprotein (LDL) cholesterol have been reported in the literature from areas where experience with antiretroviral drugs has amassed. Up until recently the use of antiretroviral drugs in Nigeria on a wide scale was a rarity owing largely to
Imarhiagbe, Frank, Kubeyinje, Emmanuel
openaire   +3 more sources

A literature review on cardiovascular risk in human immunodeficiency virus-infected patients: implications for clinical management

open access: yesBrazilian Journal of Infectious Diseases, 2013
Introduction: In recent years, there has been growing concern about an increasing rate of cardiovascular diseases in human immunodeficiency virus-infected patients, which could be associated with side effects of highly active antiretroviral therapy.
Mansueto Gomes Neto   +2 more
doaj   +3 more sources

Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries [PDF]

open access: yes, 2009
BACKGROUND: In developing countries, access to laboratory tests remains limited, and the use of simple tools such as weight to monitor HIV-infected patients treated with antiretroviral therapy should be evaluated.
Arnaud Fontanet   +33 more
core   +3 more sources

Personalizing HIV therapy, mission impossible? [PDF]

open access: yes, 2012
Sustained HIV suppression depends on a number of factors including therapy adherence, management of side effects, viral resistance and individual characteristics of patients and therapeutic settings.
Hentig, Nils von
core   +1 more source

Initiation of antiretroviral therapy

open access: yesIndian Journal of Sexually Transmitted Diseases and AIDS, 2014
With the widespread availability of antiretroviral therapy, there is a dramatic decline in HIV related morbidity and mortality in both developed and developing countries. Further, the current antiretroviral drug combinations are safer and the availability of newer monitoring assays and guidelines has vastly improved the patient management.
Pandhi, Deepika, Ailawadi, Pallavi
openaire   +3 more sources

Training needs assessment for clinicians at antiretroviral therapy clinics: evidence from a national survey in Uganda

open access: yesHuman Resources for Health, 2009
Background To increase access to antiretroviral therapy in resource-limited settings, several experts recommend "task shifting" from doctors to clinical officers, nurses and midwives.
Namagala Elizabeth   +10 more
doaj   +1 more source

Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda [PDF]

open access: yes, 2011
Little is known about the effect of combination antiretroviral therapy (cART) on life expectancy in sub-Saharan ...
Bakanda, Celestin   +8 more
core   +2 more sources

Antiretroviral Side Effects on Adherence in People Living with HIV/AIDS

open access: yesNurse Media: Journal of Nursing, 2018
Background: Antiretroviral therapy is a lifelong treatment in people living with HIV/AIDS (PLWHA). Adherence is the key to the effectiveness of antiretroviral therapy.
Gede Arya Bagus Arisudhana   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy